Insomnia is not a listed side effect of Zepbound from clinical trials. Fatigue was more commonly reported. While not a typical side effect, sleep disturbances could arise indirectly from Zepbound’s ...

One in eight American adults is taking GLP-1s. What does that mean for how we relate to our food, bodies and one another?

SureNano Science is developing GEP-44 as a patented next-generation metabolic therapy designed to address the limitations of ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today presented additional data ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...